This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liehr, J. G. Search for Related Content PubMed PubMed Citation Articles by Liehr, J. G.

Is Estradiol a Genotoxic Mutagenic Carcinogen?¹

The Stehlin Foundation for Cancer Research, Houston, Texas 77003

The natural hormone 17ß-estradiol (E₂) induces tumors in various organs of rats, mice, and hamsters. In humans, slightly elevated circulating estrogen levels caused either by increased endogenous hormone production or by therapeutic doses of estrogen medications increase breast or uterine cancer risk. Several epigenetic mechanisms of tumor induction by this hormone have been proposed based on its lack of mutagenic activity in bacterial and mammalian cell test systems. More recent evidence supports a dual role of estrogen in carcinogenesis as a hormone stimulating cell proliferation and as a procarcinogen inducing genetic damage. Tumors may be initiated by metabolic conversion of E₂ to 4-hydroxyestradiol catalyzed by a specific 4-hydroxylase (CYP1B1) and by further activation of this catechol to reactive semiquinone/quinone intermediates. Several types of direct and indirect free radical-mediated DNA damage are induced by E₂, 4-hydroxyestradiol, or its corresponding quinone in cell-free systems, in cells in culture, and/or in vivo. E₂ also induces various chromosomal and genetic lesions including aneuploidy, chromosomal aberrations, gene amplification, and microsatellite instability in cells in culture and/or in vivo and gene mutations in several cell test systems. These data suggest that E₂ is a weak carcinogen and weak mutagen capable of inducing genetic lesions with low frequency. Tumors may develop by hormone receptor-mediated proliferation of such damaged cells.

This article has been cited by other articles:

				J. G. Bromer, J. Wu, Y. Zhou, and H. S. Taylor Hypermethylation of Homeobox A10 by in Utero Diethylstilbestrol Exposure: An Epigenetic Mechanism for Altered Developmental Programming Endocrinology, July 1, 2009; 150(7): 3376 - 3382. [Abstract] [Full Text] [PDF]

				M. KULENDRAN, M. SALHAB, and K. MOKBEL Oestrogen-Synthesising Enzymes and Breast Cancer Anticancer Res, April 1, 2009; 29(4): 1095 - 1109. [Abstract] [Full Text] [PDF]

				Z. Wang, G. T. Wijewickrama, K.-w. Peng, B. M. Dietz, L. Yuan, R. B. van Breemen, J. L. Bolton, and G. R. J. Thatcher Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus J. Biol. Chem., March 27, 2009; 284(13): 8633 - 8642. [Abstract] [Full Text] [PDF]

				R. T. Falk, X. Xu, L. Keefer, T. D. Veenstra, and R. G. Ziegler A Liquid Chromatography-Mass Spectrometry Method for the Simultaneous Measurement of 15 Urinary Estrogens and Estrogen Metabolites: Assay Reproducibility and Interindividual Variability Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3411 - 3418. [Abstract] [Full Text] [PDF]

				M. Canonico, E. Bouaziz, L. Carcaillon, C. Verstuyft, A. Guiochon-Mantel, L. Becquemont, P.-Y. Scarabin, and for the Estrogen Thromboembolism Risk (ESTHER) Stu Synergism between Oral Estrogen Therapy and Cytochrome P450 3A5*1 Allele on the Risk of Venous Thromboembolism among Postmenopausal Women J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3082 - 3087. [Abstract] [Full Text] [PDF]

				X. R. Yang, R. M. Pfeiffer, M. Garcia-Closas, D. L. Rimm, J. Lissowska, L. A. Brinton, B. Peplonska, S. M. Hewitt, R. W. Cartun, D. Mandich, et al. Hormonal Markers in Breast Cancer: Coexpression, Relationship with Pathologic Characteristics, and Risk Factor Associations in a Population-Based Study Cancer Res., November 1, 2007; 67(21): 10608 - 10617. [Abstract] [Full Text] [PDF]

				M. G. Manjanatha, S. Shelton, M. E. Bishop, L. E. Lyn-Cook, and A. Aidoo Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue(R) transgenic rats. Carcinogenesis, December 1, 2006; 27(12): 2555 - 2564. [Abstract] [Full Text] [PDF]

				M. Manjanatha, S. Shelton, M. Bishop, L. Lyn-Cook, and A. Aidoo Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats Carcinogenesis, October 1, 2006; 27(10): 1970 - 1979. [Abstract] [Full Text] [PDF]

				Y. Wang, K. W. Lee, F. L. Chan, S. Chen, and L. K. Leung The Red Wine Polyphenol Resveratrol Displays Bilevel Inhibition on Aromatase in Breast Cancer Cells Toxicol. Sci., July 1, 2006; 92(1): 71 - 77. [Abstract] [Full Text] [PDF]

				J. D. Yager and N. E. Davidson Estrogen Carcinogenesis in Breast Cancer N. Engl. J. Med., January 19, 2006; 354(3): 270 - 282. [Full Text] [PDF]

				J. Thibaudeau, J. Lepine, J. Tojcic, Y. Duguay, G. Pelletier, M. Plante, J. Brisson, B. Tetu, S. Jacob, L. Perusse, et al. Characterization of Common UGT1A8, UGT1A9, and UGT2B7 Variants with Different Capacities to Inactivate Mutagenic 4-Hydroxylated Metabolites of Estradiol and Estrone Cancer Res., January 1, 2006; 66(1): 125 - 133. [Abstract] [Full Text] [PDF]

				I. Cousineau, C. Abaji, and A. Belmaaza BRCA1 Regulates RAD51 Function in Response to DNA Damage and Suppresses Spontaneous Sister Chromatid Replication Slippage: Implications for Sister Chromatid Cohesion, Genome Stability, and Carcinogenesis Cancer Res., December 15, 2005; 65(24): 11384 - 11391. [Abstract] [Full Text] [PDF]

				T. Suzuki, Y. Miki, Y. Nakamura, T. Moriya, K. Ito, N. Ohuchi, and H. Sasano Sex steroid-producing enzymes in human breast cancer Endocr. Relat. Cancer, December 1, 2005; 12(4): 701 - 720. [Abstract] [Full Text] [PDF]

				P. W. Parodi Dairy Product Consumption and the Risk of Breast Cancer J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 556S - 568S. [Abstract] [Full Text] [PDF]

				C. Dabrosin Increased extracellular local levels of estradiol in normal breast in vivo during the luteal phase of the menstrual cycle J. Endocrinol., October 1, 2005; 187(1): 103 - 108. [Abstract] [Full Text] [PDF]

				G. Lurie, G. Maskarinec, R. Kaaks, F. Z. Stanczyk, and L. Le Marchand Association of Genetic Polymorphisms with Serum Estrogens Measured Multiple Times During a 2-Year Period in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1521 - 1527. [Abstract] [Full Text] [PDF]

				C. Abaji, I. Cousineau, and A. Belmaaza BRCA2 Regulates Homologous Recombination in Response to DNA Damage: Implications for Genome Stability and Carcinogenesis Cancer Res., May 15, 2005; 65(10): 4117 - 4125. [Abstract] [Full Text] [PDF]

				T. Brake and P. F. Lambert Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model PNAS, February 15, 2005; 102(7): 2490 - 2495. [Abstract] [Full Text] [PDF]

				K. Muller-Decker, I. Berger, K. Ackermann, V. Ehemann, S. Zoubova, S. Aulmann, W. Pyerin, and G. Furstenberger Cystic Duct Dilatations and Proliferative Epithelial Lesions in Mouse Mammary Glands upon Keratin 5 Promoter-Driven Overexpression of Cyclooxygenase-2 Am. J. Pathol., February 1, 2005; 166(2): 575 - 584. [Abstract] [Full Text] [PDF]

				W. Yue, J.-P. Wang, Y. Li, W. P. Bocchinfuso, K. S. Korach, P. D. Devanesan, E. Rogan, E. Cavalieri, and R. J. Santen Tamoxifen versus Aromatase Inhibitors for Breast Cancer Prevention Clin. Cancer Res., January 15, 2005; 11(2): 925s - 930s. [Abstract] [Full Text] [PDF]

				M. Yoshida, S. Katashima, J. Ando, T. Tanaka, F. Uematsu, D. Nakae, and A. Maekawa Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N'-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism Carcinogenesis, November 1, 2004; 25(11): 2257 - 2264. [Abstract] [Full Text] [PDF]

				V K Turan, R I Sanchez, J J Li, S A Li, K R Reuhl, P E Thomas, A H Conney, M A Gallo, F C Kauffman, and S Mesia-Vela The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17{beta}-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16{alpha}-hydroxyestradiol, and 4-hydroxyestrone J. Endocrinol., October 1, 2004; 183(1): 91 - 99. [Abstract] [Full Text] [PDF]

				J. Lepine, O. Bernard, M. Plante, B. Tetu, G. Pelletier, F. Labrie, A. Belanger, and C. Guillemette Specificity and Regioselectivity of the Conjugation of Estradiol, Estrone, and Their Catecholestrogen and Methoxyestrogen Metabolites by Human Uridine Diphospho-glucuronosyltransferases Expressed in Endometrium J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5222 - 5232. [Abstract] [Full Text] [PDF]

				S. J. Ellem, J. F. Schmitt, J. S. Pedersen, M. Frydenberg, and G. P. Risbridger Local Aromatase Expression in Human Prostate Is Altered in Malignancy J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2434 - 2441. [Abstract] [Full Text] [PDF]

				R. De Bont and N. van Larebeke Endogenous DNA damage in humans: a review of quantitative data Mutagenesis, May 1, 2004; 19(3): 169 - 185. [Abstract] [Full Text] [PDF]

				K.-M. Li, R. Todorovic, P. Devanesan, S. Higginbotham, H. Kofeler, R. Ramanathan, M. L. Gross, E. G. Rogan, and E. L. Cavalieri Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo Carcinogenesis, February 1, 2004; 25(2): 289 - 297. [Abstract] [Full Text] [PDF]

				B. Maecker, D. H. Sherr, R. H. Vonderheide, M. S. von Bergwelt-Baildon, N. Hirano, K. S. Anderson, Z. Xia, M. O. Butler, K. W. Wucherpfennig, C. O'Hara, et al. The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells Blood, November 1, 2003; 102(9): 3287 - 3294. [Abstract] [Full Text] [PDF]

				A. J. Lee, A. H. Conney, and B. T. Zhu Human Cytochrome P450 3A7 Has a Distinct High Catalytic Activity for the 16{alpha}-Hydroxylation of Estrone but not 17{beta}-Estradiol Cancer Res., October 1, 2003; 63(19): 6532 - 6536. [Abstract] [Full Text] [PDF]

				T. Rylander-Rudqvist, S. Wedren, F. Granath, K. Humphreys, S. Ahlberg, E. Weiderpass, M. Oscarson, M. Ingelman-Sundberg, and I. Persson Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk Carcinogenesis, September 1, 2003; 24(9): 1533 - 1539. [Abstract] [Full Text] [PDF]

				A. J. Lee, M. X. Cai, P. E. Thomas, A. H. Conney, and B. T. Zhu Characterization of the Oxidative Metabolites of 17{beta}-Estradiol and Estrone Formed by 15 Selectively Expressed Human Cytochrome P450 Isoforms Endocrinology, August 1, 2003; 144(8): 3382 - 3398. [Abstract] [Full Text] [PDF]

				N. R. Bianco, G. Perry, M. A. Smith, D. J. Templeton, and M. M. Montano Functional Implications of Antiestrogen Induction of Quinone Reductase: Inhibition of Estrogen-Induced Deoxyribonucleic Acid Damage Mol. Endocrinol., July 1, 2003; 17(7): 1344 - 1355. [Abstract] [Full Text] [PDF]

				P. Gibson, J. H. Gill, P. A. Khan, J. M. Seargent, S. W. Martin, P. A. Batman, J. Griffith, C. Bradley, J. A. Double, M. C. Bibby, et al. Cytochrome P450 1B1 (CYP1B1) Is Overexpressed in Human Colon Adenocarcinomas Relative to Normal Colon: Implications for Drug Development Mol. Cancer Ther., June 1, 2003; 2(6): 527 - 534. [Abstract] [Full Text] [PDF]

				H. Stopper, E. Schmitt, C. Gregor, S. O. Mueller, and W. H. Fischer Increased cell proliferation is associated with genomic instability: elevated micronuclei frequencies in estradiol-treated human ovarian cancer cells Mutagenesis, May 1, 2003; 18(3): 243 - 247. [Abstract] [Full Text] [PDF]

				E. G. Rogan, A. F. Badawi, P. D. Devanesan, J. L. Meza, J. A. Edney, W. W. West, S. M. Higginbotham, and E. L. Cavalieri Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer Carcinogenesis, April 1, 2003; 24(4): 697 - 702. [Abstract] [Full Text] [PDF]

				H. K. Bhat, G. Calaf, T. K. Hei, T. Loya, and J. V. Vadgama Critical role of oxidative stress in estrogen-induced carcinogenesis PNAS, April 1, 2003; 100(7): 3913 - 3918. [Abstract] [Full Text] [PDF]

				L. A. M. Castagnetta, O. M. Granata, A. Traina, B. Ravazzolo, M. Amoroso, M. Miele, V. Bellavia, B. Agostara, and G. Carruba Tissue Content of Hydroxyestrogens in Relation to Survival of Breast Cancer Patients Clin. Cancer Res., October 1, 2002; 8(10): 3146 - 3155. [Abstract] [Full Text] [PDF]

				C. Kennedy, K. Byth, C. L. Clarke, and A. deFazio Cell Proliferation in the Normal Mouse Mammary Gland and Inhibition by Phenylbutyrate Mol. Cancer Ther., October 1, 2002; 1(12): 1025 - 1033. [Abstract] [Full Text] [PDF]

				A. J. Lee, L. H. Mills, J. W. Kosh, A. H. Conney, and B. T. Zhu NADPH-Dependent Metabolism of Estrone by Human Liver Microsomes J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 838 - 849. [Abstract] [Full Text] [PDF]

				C. J. Gruber, W. Tschugguel, C. Schneeberger, and J. C. Huber Production and Actions of Estrogens N. Engl. J. Med., January 31, 2002; 346(5): 340 - 352. [Full Text] [PDF]

				D. Roy, G. Calaf, and T. K. Hei Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic transformation of human breast epithelial cells Carcinogenesis, October 1, 2001; 22(10): 1685 - 1692. [Abstract] [Full Text] [PDF]

				S. Dawling, N. Roodi, R. L. Mernaugh, X. Wang, and F. F. Parl Catechol-O-Methyltransferase (COMT)-mediated Metabolism of Catechol Estrogens: Comparison of Wild-Type and Variant COMT Isoforms Cancer Res., September 1, 2001; 61(18): 6716 - 6722. [Abstract] [Full Text] [PDF]

				A. J. Lee, J. W. Kosh, A. H. Conney, and B. T. Zhu Characterization of the NADPH-Dependent Metabolism of 17beta -Estradiol to Multiple Metabolites by Human Liver Microsomes and Selectively Expressed Human Cytochrome P450 3A4 and 3A5 J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 420 - 432. [Abstract] [Full Text] [PDF]

				L. Zheng, L. A. Annab, C. A. Afshari, W.-H. Lee, and T. G. Boyer BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor PNAS, August 1, 2001; (2001) 171174298. [Abstract] [Full Text] [PDF]

				M. Karbownik, R. J. Reiter, S. Burkhardt, E. Gitto, D.-X. Tan, and A. Lewinski Melatonin Attenuates Estradiol-Induced Oxidative Damage to DNA: Relevance for Cancer Prevention Experimental Biology and Medicine, July 1, 2001; 226(7): 707 - 712. [Abstract] [Full Text] [PDF]

				G. Thordarson, K. Van Horn, R. C. Guzman, S. Nandi, and F. Talamantes Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones Carcinogenesis, July 1, 2001; 22(7): 1027 - 1033. [Abstract] [Full Text] [PDF]

				H. Leffers, M. Nasby, B. Vendelbo, N. E. Skakkebak, and M. Jorgensen Oestrogenic potencies of Zeranol, oestradiol, diethylstilboestrol, Bisphenol-A and genistein: implications for exposure assessment of potential endocrine disrupters Hum. Reprod., May 1, 2001; 16(5): 1037 - 1045. [Abstract] [Full Text] [PDF]

				K. Mitrunen, N. Jourenkova, V. Kataja, M. Eskelinen, V.-M. Kosma, S. Benhamou, H. Vainio, M. Uusitupa, and A. Hirvonen Glutathione S-Transferase M1, M3, P1, and T1 Genetic Polymorphisms and Susceptibility to Breast Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 229 - 236. [Abstract] [Full Text]

				P. E. Goss and K. Strasser Aromatase Inhibitors in the Treatment and Prevention of Breast Cancer J. Clin. Oncol., February 1, 2001; 19(3): 881 - 894. [Abstract] [Full Text] [PDF]

				J. M. Ward, M. Yoon, M. R. Anver, D. C. Haines, G. Kudo, F. J. Gonzalez, and S. Kimura Hyalinosis and Ym1/Ym2 Gene Expression in the Stomach and Respiratory Tract of 129S4/SvJae and Wild-Type and CYP1A2-Null B6,129 Mice Am. J. Pathol., January 1, 2001; 158(1): 323 - 332. [Abstract] [Full Text] [PDF]

				L. Hilakivi-Clarke Estrogens, BRCA1, and Breast Cancer Cancer Res., September 1, 2000; 60(18): 4993 - 5001. [Abstract] [Full Text]

				L. Zheng, L. A. Annab, C. A. Afshari, W.-H. Lee, and T. G. Boyer BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor PNAS, August 14, 2001; 98(17): 9587 - 9592. [Abstract] [Full Text] [PDF]

				J. Teng, Z.-Y. Wang, and D. E. Bjorling Estrogen-induced proliferation of urothelial cells is modulated by nerve growth factor Am J Physiol Renal Physiol, June 1, 2002; 282(6): F1075 - F1083. [Abstract] [Full Text] [PDF]